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Point:Counterpoint Comments
The following letters are in response to Point:Counterpoint:
High-frequency ventilation is/is not the optimal physiological
approach to ventilate ARDS patients.
To the Editor: Mechanical ventilation (MV) may aggravate
lung injury due to two primary types of injury: volu- and
atelectrauma. There is a variety of experimental data clearly
showing that avoidance of alveolar overdistension and repeti-
tive collapse and reopening of damaged alveolar lung units
leads to lung protection (3). In clinical studies the application
of lower tidal volumes (VT) was associated with improvements
in outcome (1). Outcome was not affected by the level of
positive- end-expiratory pressure (2). Thus low-VT ventilation
seems to be the key factor to reduce mortality, whereas the
optimal VT remains unclear. At this point, there is growing
evidence to suggest that a further VT reduction might be
beneficial for ARDS patients. Due to a number of different
CO2-removal mechanisms, VT during high-frequency oscilla-
tory ventilation (HFOV) may further be decreased (in the range
of 1.0–2.0 ml/kg), thereby minimizing the potential of
volutrauma (4, 5, 6). During conventional MV, a further VT
reduction (4 ml/kg) would inevitably result in an unaccept-
ably high level of hypercapnic acidosis. Therefore, alternative
techniques of ventilation, such as arteriovenous extracorporeal
CO2 removal (av-ECLA), must be considered during conven-
tional MV to achieve the same low-VT that is possible during
HFOV. However, a further minimization of VT with maximal
oscillatory frequencies (10–15 Hz) would also be possible if
av-ECLA is combined with HFOV. Thereby, av-ECLA may
contribute significantly to the goals of lung-protective ventila-
tion strategies, raising the following question: What is the
optimal ventilatory strategy during av-ECLA—conventional
MV or HFOV?
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To the Editor: Although mammals are scaled similarly and
have a tidal volume of 6.3 ml/kg body wt (6), it is possible
to adequately ventilate small and medium body sized mammals
and humans of all ages with healthy or diseased lungs using
very small volumes (less than anatomic dead space) (5). The
use of small tidal volume is the key to lung-protective conven-
tional mechanical ventilation (CMV). On the basis of an
abundance of published data, Ferguson and Slutsky (2) and
Kacmarek (3) disagree with tenacity on the issue of optimal
ventilatory management for ARDS.
In medicine, there are many “correct” theories for the same
issue, but what is true in theory may not be true in nature.
Many alternatives to CMV that were successfully tested in
animal models of ARDS, failed in humans (e.g., partial liquid
ventilation) (4). From a physiological perspective, HFO is an
excellent way of ventilating ARDS patients. However, most
studies comparing HFO with CMV used non-clinically rele-
vant models, lacked adequate sample size, and ventilation
lasted just a few hours. In addition to differences in anatomy,
pattern of respiration, and the chest shape across species (1),
these experiments did not meet equipoise: the CMV arms did
not provide lung protection.
If HFO is theoretically better than CMV, it is time to prove
it! An RCT comparing HFO to our best approach to CMV in
patients with established ARDS is needed. Until then, there is
no clinical data to support HFO as the optimal physiological
approach to ventilate ARDS.
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To the Editor: Ferguson and Slutsky (3) used abundant exper-
imental data to support the view that HFOV is the optimal
physiological approach to ventilate patients with ARDS. In his
Counterpoint, Kacmarek (4) stated that although HFOV should
theoretically be more protective than conventional ventilation,
definitive clinical evidence is still lacking.
Clinical evidence favoring HFOV is particularly scarce in
the pediatric (non-neonatal) ARDS population. A single pedi-
atric randomized controlled trial, performed before the era of
conventional ventilation with reduced tidal volumes, showed
that HFOV was associated with decreased pulmonary morbid-
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ity (1). HFOV has since become an important tool in managing
pediatric ARDS, based on solid experimental data and anec-
dotal clinical observations. As such, a well-powered multi-
center randomized pediatric trial would probably not be feasi-
ble in North America, since many pediatric intensivists would
now have ethical concerns about depriving the sickest patients
from receiving HFOV sometime along the course of treatment.
Furthermore, even if such a trial were to be conducted in the
current era of lung protective ventilation, it would be unlikely
to show superiority of HFOV over a conventional strategy, as
a properly applied protective strategy should not be more
protective than another (6).
A truly protective conventional ventilation strategy gener-
ally results in hypercapnia and elevated mean intrathoracic
pressures. Although well tolerated in adults (2), this approach
has been associated with significant hemodynamic instability
in models of pediatric ARDS under tight experimental condi-
tions (5) and in pediatric clinical practice. As such, all else
being equal, HFOV should be the optimal physiological ap-
proach to ventilate the pediatric patient with ARDS.
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To the Editor: One of the major issues in the management of
patients with ARDS is whether high-frequency ventilation is
the optimal physiological approach to ventilate them (2, 4).
Also in preterm neonates with acute pulmonary dysfunction,
there is no clear evidence that elective high-frequency oscilla-
tory ventilation (HFOV), as compared with conventional me-
chanical ventilation (CMV), offers important advantages when
used as the initial ventilation strategy (3). In particular, the
bronchopulmonary dysplasia rate is only reduced with HFOV
in some trials where a high lung volume strategy (HLVS) was
used. The question is: was lung volume optimization equally
effective in all “HLVS” trials? In our experience (6) an FIO2 
0.26 was chosen as an index of optimal lung volume. It is not
reasonably correct to consider an FIO2 of 0.40 or more, used in
other trials (5), as marker of ideal lung volume, because in this
situation an important V/Q alteration exists. The objectives of
future research in both neonatal and adult patients should be:
1) to explore the importance of specific patient-level factors
(for neonates: antenatal corticosteroids, gestational age, birth
weight, severity of lung disease, postnatal age at start of
HFOV) as effect modifiers, to outline a risk profile of each
infant and then target those patients who could have maximal
benefit from being ventilated in HFOV modality; 2) to reex-
amine the importance of trial design-level factors (HFOV
device/settings, HFOV strategy-optimal lung volume and
CMV strategy-lung protective ventilation adopted), to explain
the heterogeneity of the trials (6).
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To the Editor: This debate (2, 3) has not arisen from flaws in
the physiological principles, but from a growing inappropri-
ateness of the populations enrolled in ventilator trials.
In the 1980s and 90s, early randomization was advocated to
limit exposure of the HFO-managed patients to the injurious
CV patterns then in use. As CV became more lung protective,
the “start line” for both clinical and animal RCTs should have
moved progressively to include only subjects with lungs that
proved resistant to the reversal of ongoing atelectasis despite
lung-protective CV. Instead, 1994 Consensus Guidelines for
the diagnosis of ARDS have directed most human study
enrollment, with successfully recruitable lung injury models
dominating animal studies.
In Villar’s (6) recent study, patients meeting the classic 1994
PaO2/FIO2 criterion for ARDS (i.e., without specific FIO2 and
PEEP requirements) had mortality rates varying from 6.3% to
45.5%. A ventilator effect would be improbable in the first
subgroup, but worth looking for in the latter patients.
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Despite major advances, lung-protective CV protocols can-
not achieve optimal aeration in all patients with ARDS. Ter-
ragni et al. (5) report a population in which alveolar reexpan-
sion could not be achieved and maintained in a substantial
volume of lung, and tidal hyperinflation occurred while using
the ARDSnet protocol. In two large neonatal HFO trials,
benefit occurred only in the study limiting enrollment to sicker
babies (4). Bollen et al. (1) hypothesized that an HFO treatment
effect will likely occur only in patients with more severe
disease.
The flaw is not in the physiology, but in existing study
design.
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To the Editor: In their debate, Ferguson and Slutsky and
Kacmarek refer to two studies published by our research group
(1, 2). Using apparently the same evidence, they reach opposite
conclusions about whether high-frequency ventilation (HFV) is
the optimal physiological approach to ventilate ARDS patients
(3, 4). A similar discussion has been conducted among neona-
tologists (1). There is overwhelming theoretical and animal
evidence in support of HFV, on the other hand this has not
been confirmed in randomized trials. This apparent gap be-
tween theory and practice could be because of heterogeneity of
the disease. We propose a different starting point. There may
be ARDS patients with either such a favorable or such a poor
prognosis that HFV will not make a difference. The same line
of reasoning has been used to explain differences between
trials comparing low with high tidal volumes (5). The theoret-
ical existence of a safe window between atelectasis and over
inflation of the lung supports this view (6). This safe window
may limit tidal volumes to an extent that only HFV can be used
for adequate ventilation. It is not yet clear how to assess this
safe window. In our randomized trial, patients with a low
oxygenation index and patients with a very high oxygenation
index did not seem to benefit from HFV. Mortality in patients
with an oxygenation index in between, however, showed a
trend in favor of HFV (2). Therefore, we propose to reverse the
question to: Which ARDS patients are the optimal candidates
for high-frequency ventilation?
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To the Editor: Both supporter (4) and detractor (6) agree that
high-frequency oscillation (HFO) theoretically should be more
lung protective than conventional ventilation (CV). The main
point to be debated is whether HFO can really modify outcome
in ARDS patients. To answer this question we have to consider
that clinical knowledge and operative learning in intensive care
medicine are complex and extremely time consuming phenom-
ena. Since Dreyfuss et al.’s (3) experimental studies on ani-
mals, a decade passed until lung protective CV was applied in
clinical practice (1). However, even if intensivists are nowa-
days confident in all aspects of CV, being such ventilation
mode part of the daily routine in intensive care patient treat-
ment, still in ARDS patients CV must be tailored because “one
size does not fit all” (2): each patient needs specific assessment
of his/her clinical condition and a personalized setting of a
coherent ventilation strategy.
Animal studies suggest that HFO reduces ventilation-in-
duced lung injury (VILI) in neonatal and adult models (5).
Discordant results at the moment are coming from scanty
randomized clinical trials on ARDS patients (4, 6). HFO is a
complex ventilatory technique with many variables (measure-
ment of tidal volume delivery and its dependence on endotra-
cheal tube size). Moreover, clinical experience on HFO is
limited to specialized ICU settings and a commercially avail-
able ventilator has been introduced only ten years ago. Before
discarding HFO, enough time must be allowed for the devel-
opment of this technique to its full potential.
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To the Editor: A central feature of this debate (2, 4) is the
disparity between studies in animal models, which have pro-
vided a physiological rationale for HFO, and clinical studies,
which have been hard pressed to show an advantage. One of
the main physiological rationales for HFO is its avoidance of
atelectrauma. In clinical studies (3) and laboratory studies, the
usual way to assess potential for cyclical recruitment and
derecruitment (R/D) is to measure the amount of atelectasis at
end-inspiratory and end-expiratory breath-holds and extrapo-
late these values to tidal breathing. This approach assumes that
the instantaneous airway pressure is the only relevant param-
eter, which is implicitly assuming that R/D are nearly instan-
taneous. Recent studies in animal models, however, have
suggested that the time constants for R/D are not zero (5, 6).
The result is that cyclical recruitment is profoundly sensitive to
respiratory rate, even at conventional respiratory rates (1). No
measures to assess R/D dynamics have been applied in ARDS,
and the time constants for recruitment and derecruitment are
not currently known. If the time constants are faster in ARDS
than in experimental models, the usual assumptions will give
good approximations. If, on the other hand, the time constants
are on par with experimental models, or slower, then the usual
assumptions might infer a particular patient is undergoing
atelectrauma, when in fact they are not. It is perhaps not so
surprising that an optimum frequency for ventilation has been
difficult to define in clinical studies, given that the dynamics of
recruitment and derecruitment are so poorly characterized in
ARDS.
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